Healthcare Analytics Market Analysis 2026

FLEX MARKETING, a fresh and independent agency, officially launches with a mission to revolutionize healthcare marketing. Its flexible and innovative approach is tailored to meet the challenges faced by pharmaceutical, biotech, medical device, diagnostic, and health tech brands, helping them stay competitive in a rapidly changing healthcare landscape. With a focus on flexibility and adaptability, FLEX offers customized strategic and creative solutions designed to boost market impact and maximize brand potential with speed, innovation, and effectiveness.

Founded by experienced industry leaders Adam Gelling, Amber Rogers, Jason Luis, and Michelle Green, FLEX brings decades of expertise to deliver a results-oriented, value-driven agency designed to meet each client's specific needs.

Services include:

• Research & Insight Generation: Efficient market and customer research to uncover valuable insights that drive brand strategy and decisions.
• Strategic Planning: Customized plans from expert partners that align with a brand’s goals and objectives.
• Market Conditioning & Brand Development: Innovative strategies for shaping market positioning and perception.
• Creative Execution: Engaging, impactful creative solutions tailored to resonate with target audiences.
• Analytics & Reporting: Data-driven insights and performance tracking to optimize marketing efforts.

Based on the West Coast, FLEX works as an integrated partner with clients across the U.S. and internationally. Clients can easily engage FLEX on a project basis, fill gaps in their teams or partnerships, and access on-demand execution resources.

Source Link: https://www.prnewswire.com/news-releases/flex-marketing-launches-to-redefine-the-healthcare-agency-model-302376287.html

Provident Healthcare Partners, a prominent healthcare investment banking firm, announced that it advised Acentus in the acquisition of nearly all its assets by Henry Schein, Inc. Acentus, a nationwide medical supplier, specializes in Continuous Glucose Monitors (CGMs).

Acentus' founders Brett Carroll, Todd Cianfrocca, Greg Duvall, and Julio Valdivia will join Henry Schein, contributing their knowledge and expertise in the CGM sector and healthcare industry. Provident's deal team was led by Managing Director Kevin Palamara, and Robinson & Cole provided legal counsel to Acentus. The acquisition was publicly announced on November 20, 2024.

Source Link: https://www.prnewswire.com/news-releases/provident-healthcare-partners-advises-acentus-in-its-acquisition-by-henry-schein-302352624.html

Mankind Pharma has agreed to give Catalyst Trusteeship Ltd 39.68% of its equity stake in Bharat Serums and Vaccines Ltd (BSV), a fully owned subsidiary, in exchange for non-convertible debentures (NCDs) valued at Rs 5,000 crore.
The action is in accordance with three debenture trust deeds that were signed on October 10 and that allowed for the issuance of Rs 5,000 crore worth of listed, graded, secured, redeemable, and transferable NCDs. 
The November 14 formalization of the pledge agreement guarantees that BSV's equity shares will stay pledged until the NCDs are settled. For the interest of NCD holders, Catalyst Trusteeship will serve as the common security trustee.  
Mankind Pharma declared in September that it would use commercial papers (CPs) and NCDs to raise up to Rs 10,000 crore through private placement.

Source Link: https://www.business-standard.com/companies/news/mankind-pharma-pledges-39-68-stake-in-bharat-serums-for-rs-5k-cr-ncds-124111501333_1.html

The Islamic Development Bank (IsDB) today announced a significant grant allocation of US$ 10 million to WHO to execute the Health Impact Investment Platform (HIIP), as part of its commitment to the global initiative to strengthen primary health care and health systems resilience.
The HIIP is a ground-breaking partnership between WHO, Multilateral Development Banks (MDBs), and nations that require strong climate and health solutions. The investment in critical, climate- and crisis-resilient primary health care systems and services is the main goal of this effort. Its ultimate goal is to promote resilience against new health threats and climatic issues by strengthening the health system, particularly in low- and middle-income nations and underprivileged areas.
The IsDB grant of US$10 million will specifically help WHO's technical assistance to nations worldwide in determining their investment needs and creating the most effective health programs. The MDBs will use these projects as the basis for their co-investment, guaranteeing that funds are allocated to locations that have the best chance of producing favorable health results.

Source Link: https://www.who.int/news/item/12-11-2024-isdb-joins-efforts-with-who-and-development-partners-to-promote-health-impact-investment

WHO wants member governments to contribute more money to a new global health plan to save 40 million lives. G20 meeting to increase pledges. According to a statement released by the UN health agency, the World Health Organization (WHO) is looking for more money from member states for its investment round to finance a new global health strategy.
Health ministers urged all members and partners to participate in a G20 conference hosted by Brazil on Saturday. According to the WHO statement, the G20 Leaders' Summit, which will be chaired by the president of Brazil and take place on November 18–19, will be a significant event where more G20 nations and other participants are anticipated to commit funds.

Source Link: https://www.hindustantimes.com/india-news/up-funds-for-new-global-health-plan-who-nations-told-101730660883028.html